Opinion

Video

Choosing Second-Line Therapies: Considering First Line Therapy Received

Panelists discuss how to determine appropriate second-line and subsequent therapies for unresectable hepatocellular carcinoma after frontline treatment, emphasizing patient-specific factors and alternatives to clinical trial enrollment.

Video content above is prompted by the following:

Dr El-Khoueiry/Dr Kudo: After frontline therapy in unresectable hepatocellular carcinomauHCC, how do you determine the appropriate second- line and beyond therapy?
• What patient-specific factors do you consider?
• Other than clinical trial enrollment, what would you consider for second-line2L treatment?

Related Videos
Related Content